Nova Leap Health Corp.
NVLPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $8,264 | $8,021 | $7,094 | $6,586 |
| % Growth | 3% | 13.1% | 7.7% | – |
| Cost of Goods Sold | $4,992 | $4,797 | $4,327 | $4,011 |
| Gross Profit | $3,273 | $3,224 | $2,767 | $2,574 |
| % Margin | 39.6% | 40.2% | 39% | 39.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2,621 | $2,665 | $2,495 | $2,205 |
| SG&A Expenses | $2,621 | $2,665 | $2,495 | $2,205 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $233 | $209 | $197 | $148 |
| Operating Expenses | $2,854 | $2,873 | $2,692 | $2,353 |
| Operating Income | $419 | $350 | $75 | $221 |
| % Margin | 5.1% | 4.4% | 1.1% | 3.4% |
| Other Income/Exp. Net | $168 | -$929 | -$152 | $860 |
| Pre-Tax Income | $587 | -$579 | -$77 | $1,081 |
| Tax Expense | $161 | -$94 | $2 | $195 |
| Net Income | $426 | -$484 | -$78 | $886 |
| % Margin | 5.2% | -6% | -1.1% | 13.5% |
| EPS | 0.005 | -0.006 | -0.001 | 0.01 |
| % Growth | 187.3% | -450% | -109.7% | – |
| EPS Diluted | 0.005 | -0.006 | -0.001 | 0.01 |
| Weighted Avg Shares Out | 87,314 | 87,314 | 87,314 | 87,314 |
| Weighted Avg Shares Out Dil | 87,953 | 87,314 | 87,314 | 87,314 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $84 | $107 | $81 | $45 |
| Depreciation & Amortization | $233 | $209 | $197 | $148 |
| EBITDA | $904 | -$263 | $201 | $1,275 |
| % Margin | 10.9% | -3.3% | 2.8% | 19.4% |